Will This Genetic Testing Name's Profit Soar 950%? Earnings Are On Deck.

BREAKING: Futures Mixed On Trump Comments; Fed, Huge Earnings Due Genetic testing leader GeneDx Holdings (WGS) is Monday's pick for IBD 50 Growth Stocks To Watch. The medical services stock is climbing in a seven-week-long consolidation pattern as the company's earnings report approaches. GeneDx turned profitable in 2024, and analysts expect meteoric earnings growth for its third quarter. The IBD 50 genetics testing stock was recently highlighted as an IBD Breakout… Take a Trial Today Get instant access to ...